Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: an NI-HEART analysis
Radiotherapy (RT) is the only definitive treatment option available to patients with non-small cell lung cancer (NSCLC) deemed to be technically or medically inoperable. Contemporary RT results have been improved by the recent introduction of adjuvant immunotherapy, but outcomes remain poor, with
Source: Radiotherapy and Oncology - Category: Radiology Authors: Gerard M Walls, Conor McCann, John O'Connor, Anna O'Sullivan, David I Johnston, Jonathan McAleese, Conor K McGarry, Aidan J Cole, Suneil Jain, Karl T Butterworth, Gerard G Hanna Tags: Original Article Source Type: research
More News: Atrial Fibrillation | Cancer | Cancer & Oncology | Cardiology | Heart | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Radiology